The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 2, 2006, Pages 365-371

  Jolly, Shruti ^a   Kestin, Larry L ^a   Goldstein, Neal S ^a   Vicini, Frank A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast cancer; Breast conserving therapy; LCIS; Lobular carcinoma in situ; Radiation therapy; Recurrence

Indexed keywords

BIOLOGICAL ORGANS; CELLS; PATHOLOGY; PATIENT MONITORING; RADIOTHERAPY;

BREAST CANCER; BREAST-CONSERVING THERAPY; LOBULAR CARCINOMA IN SITU (LCIS); RECURRENCE;

ONCOLOGY;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA IN SITU; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; REOPERATION; RISK ASSESSMENT; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL;

EID: 33748296190     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.05.070     Document Type: Article

References (46)

1. Sarrazin D., Le M.G., Arriagada R., et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14 (1989) 177-184
2. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
3. Fisher B., Jeong J.H., Anderson S., et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347 (2002) 567-575
4. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332 (1995) 907-911
5. van Dongen J.A., Bartelink H., Fentiman I.S., et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 11 (1992) 15-18
6. Blichert-Toft M., Rose C., Andersen J.A., et al., Danish Breast Cancer Cooperative Group. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. J Natl Cancer Inst Monogr 11 (1992) 19-25
7. Gage I., Schnitt S.J., Nixon A.J., et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78 (1996) 1921-1928
8. Goldstein N.S., Kestin L., and Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy: A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol 120 (2003) 500-527
9. Kurtz J.M., Jacquemier J., Amalric R., et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65 (1990) 1867-1878
10. Clarke D.H., and Martinez A.A. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: A review article for surgeons, pathologists, and radiation and medical oncologists. J Clin Oncol 10 (1992) 474-483
11. Clarke D.H., Le M.G., Sarrazin D., et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11 (1985) 137-145
12. Nixon A.J., Neuberg D., Hayes D.F., et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12 (1994) 888-894
13. Vicini F.A., Eberlein T.J., Connolly J.L., et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 214 (1991) 200-204
14. Vicini F.A., Kestin L.L., Goldstein N.S., et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol 18 (2000) 296-306
15. Cornil A.V. Les tumeurs du sein (1908), Libraire Germer, Paris
16. Ewing J. Neoplastic diseases. 2nd ed. (1928), WB Saunders, Philadelphia 562
17. Foote F., and Stewart F. Lobular carcinoma in situ: A rare form of mammary carcinoma. Am J Pathol (1941) 491-496
18. Muir R. The evolution of carcinoma of the mamma. J Pathol Bacteriol 52 (1941) 155-172
19. Newman W. Lobular carcinoma of the female breast: Report of 73 cases. Ann Surg 164 (1966) 305-314
20. Newman W. In situ lobular carcinoma of the breast: Report of 26 women with 32 cancers. Ann Surg 157 (1963) 591-599
21. McDivitt R.W., Hutter R.V., Foote Jr. F.W., et al. In situ lobular carcinoma: A prospective follow-up study indicating cumulative patient risks. JAMA 201 (1967) 82-86
22. Lewison E.F., and Finney Jr. G.G. Lobular carcinoma in situ of the breast. Surg Gynecol Obstet 126 (1968) 1280-1286
23. Hutter R.V., and Foote Jr. F.W. Lobular carcinoma in situ: Long term follow-up. Cancer 24 (1969) 1081-1085
24. Hutter R.V., Snyder R.E., Lucas J.C., et al. Clinical and pathologic correlation with mammographic findings in lobular carcinoma in situ. Cancer 23 (1969) 826-839
25. Andersen J.A., Fechner R.E., Lattes R., et al. Lobular carcinoma in situ (lobular neoplasia) of the breast: A symposium. Pathol Annu 15 (1980) 193-223
26. Andersen J.A. Lobular carcinoma in situ of the breast: An approach to rational treatment. Cancer 39 (1977) 2597-2602
27. Andersen J.A. Lobular carcinoma in situ of the breast with ductal involvement: Frequency and possible influence on prognosis. Acta Pathol Microbiol Scand [A] 82 (1974) 655-662
28. Andersen J.A. Lobular carcinoma in situ: A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand [A] 82 (1974) 519-533
29. Giordano J.M., and Klopp C.T. Lobular carcinoma in situ: Incidence and treatment. Cancer 31 (1973) 105-109
30. Wheeler J.E., Enterline H.T., Roseman J.M., et al. Lobular carcinoma in situ of the breast: Long-term followup. Cancer 34 (1974) 554-563
31. Rosen P.P., Kosloff C., Lieberman P.H., et al. Lobular carcinoma in situ of the breast: Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2 (1978) 225-251
32. Haagensen C.D., Lane N., Lattes R., et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42 (1978) 737-769
33. Frykberg E.R. Lobular carcinoma in situ of the breast. Breast J 5 (1999) 296-303
34. Moran M., and Haffty B.G. Lobular carcinoma in situ as a component of breast cancer: The long-term outcome in patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys 40 (1998) 353-358
35. Abner A.L., Connolly J.L., Recht A., et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 88 (2000) 1072-1077
36. Sasson A.R., Fowble B., Hanlon A.L., et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 91 (2001) 1862-1869
37. Fisher E.R., Land S.R., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Twelve-year observations concerning lobular carcinoma in situ. Cancer 100 (2004) 238-244
38. Ben David M.A., Kleer C.G., Paramagul C., et al. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy?. Cancer 106 (2006) 28-34
39. Page D.L., and Anderson T.J. Diagnostic histopathology of the breast (1987), Churchill Livingstone, New York 129-130
40. Recht A., Silver B., Schnitt S., et al. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 11 (1985) 1271-1276
41. Solin L.J., Fowble B.L., Schultz D.J., et al. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21 (1991) 279-287
42. Freedman G., Fowble B., Hanlon A., et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44 (1999) 1005-1015
43. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90 (1998) 1371-1388
44. Anderson B.O., Li C.I., Rinn K.J., et al. Clinical management of lobular carcinoma in situ. In: Singletary E.S., Robb G.L., and Hortobagyi G.N. (Eds). Advanced therapy of breast disease. 2nd ed. (2004), BC Decker, Hamilton, Ontario, Canada 269-280
45. Habel L.A., Moe R.E., Daling J.R., et al. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg 225 (1997) 69-75
46. Page D.L., Schuyler P.A., Dupont W.D., et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: A retrospective cohort study. Lancet 361 (2003) 125-129